Loading clinical trials...
Loading clinical trials...
A Randomized, Pilot Study on the Antiviral Activity and Immunological Effects of Lopinavir/Ritonavir vs. Efavirenz in Treatment-naïve HIV-Infected Patients With CD4 Cell Counts Below 100 Cells/mm3
Conditions
Interventions
tenofovir + abacavir + lopinavir/ritonavir
tenofovir + abacavir + efavirenz
Locations
4
Spain
Hospital de Sant Pau
Barcelona, Barcelona, Spain
Hospital Vall d'Hebron
Barcelona, Barcelona, Spain
Hospital Clinic
Barcelona, Barcelona, Spain
CSU Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain
Last Updated
October 11, 2006
NCT04929028
NCT06694805
NCT04142047
NCT07428330
NCT07225530
NCT06665646
Lead Sponsor
Hospital Clinic of Barcelona
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions